FDA — authorised 22 December 2022
- Marketing authorisation holder: GENENTECH INC
- Status: approved
🇺🇸 Lunsumio in United States
FDA authorised Lunsumio on 22 December 2022
Marketing authorisation
Lunsumio in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Lunsumio approved in United States?
Yes. FDA authorised it on 22 December 2022.
Who is the marketing authorisation holder for Lunsumio in United States?
GENENTECH INC holds the US marketing authorisation.